Bridgefront Capital’s Ingevity NGVT Stock Holding History

Bridgefront Capital’s Portfolio NGVT Stock Details NGVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-2,958	Closed	-$223K	–	803
2021 Q1	$223K	Buy	+2,958	New	+$215K	0.07%	533

Other funds holding NGVT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

BBCM

Broad Bay Capital Management New York $1.18B AUM 65.45% 1-Year Est. Return

AAM

Ardevora Asset Management London, United Kingdom $1.12B AUM 26.09% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bridgefront Capital's NGVT Position: Q2 2021 in Review

Bridgefront Capital sold out of Ingevity (NGVT) in Q2 2021, closing a stake of 2,958 shares — an estimated $223K sold.

Bridgefront Capital first reported a position in NGVT in Q1 2021 and held it in 1 quarter. The position peaked at $223K in Q1 2021. 277 funds tracked by Wall St. Rank hold NGVT as of Q2 2021.

Bridgefront Capital reported no remaining Ingevity position as of Q2 2021 after selling out during the quarter.
Bridgefront Capital sold 2,958 Ingevity shares in Q2 2021, an estimated $223K.
Bridgefront Capital first reported a position in Ingevity in Q1 2021 and held it in 1 quarter.
Bridgefront Capital's Ingevity position peaked at $223K in Q1 2021.
277 funds tracked by Wall St. Rank held Ingevity as of Q2 2021.

Based on Bridgefront Capital's 13F filing for Q2 2021, filed 12 Aug 2021.